CREB, cellular excitability, and cognition: Implications for aging

Xiao Wen Yu, M Matthew Oh, John F Disterhoft*

*Corresponding author for this work

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Humans and laboratory animals display cognitive deficits as they age. However, there are currently no effective therapies available to treat these deficits, as the underlying mechanisms are poorly understood. Studies using pharmacological compounds have found a link between cognitive performance and the intrinsic cellular excitability of CA1 hippocampal neurons. Therefore, it is of great interest to identify molecular regulators that may be influencing both cognition and neuronal excitability, which could be changed with age. One possible regulator is the transcription factor cAMP response element binding-protein (CREB). In young adult animals, manipulation of CREB activity has resulted in modulation of both cognitive performance on behavioral tasks, and neuronal excitability. While evidence is sparse, studies also point to a dysfunction in CREB signaling with aging. We propose that CREB may be a viable therapeutic target for the treatment of age-related cognitive deficits, along with potential experiments to test this hypothesis.

Original languageEnglish (US)
Pages (from-to)206-211
Number of pages6
JournalBehavioural Brain Research
Volume322
DOIs
StatePublished - Mar 30 2017

Fingerprint

Cyclic AMP Response Element-Binding Protein
Cognition
Laboratory Animals
Young Adult
Transcription Factors
Therapeutics
Pharmacology
Neurons

Keywords

  • Aging
  • CA1
  • CREB
  • Cognition
  • Hippocampus

ASJC Scopus subject areas

  • Behavioral Neuroscience

Cite this

@article{fda1802837264d22a6cbf759200a4ef3,
title = "CREB, cellular excitability, and cognition: Implications for aging",
abstract = "Humans and laboratory animals display cognitive deficits as they age. However, there are currently no effective therapies available to treat these deficits, as the underlying mechanisms are poorly understood. Studies using pharmacological compounds have found a link between cognitive performance and the intrinsic cellular excitability of CA1 hippocampal neurons. Therefore, it is of great interest to identify molecular regulators that may be influencing both cognition and neuronal excitability, which could be changed with age. One possible regulator is the transcription factor cAMP response element binding-protein (CREB). In young adult animals, manipulation of CREB activity has resulted in modulation of both cognitive performance on behavioral tasks, and neuronal excitability. While evidence is sparse, studies also point to a dysfunction in CREB signaling with aging. We propose that CREB may be a viable therapeutic target for the treatment of age-related cognitive deficits, along with potential experiments to test this hypothesis.",
keywords = "Aging, CA1, CREB, Cognition, Hippocampus",
author = "Yu, {Xiao Wen} and Oh, {M Matthew} and Disterhoft, {John F}",
year = "2017",
month = "3",
day = "30",
doi = "10.1016/j.bbr.2016.07.042",
language = "English (US)",
volume = "322",
pages = "206--211",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

CREB, cellular excitability, and cognition : Implications for aging. / Yu, Xiao Wen; Oh, M Matthew; Disterhoft, John F.

In: Behavioural Brain Research, Vol. 322, 30.03.2017, p. 206-211.

Research output: Contribution to journalArticle

TY - JOUR

T1 - CREB, cellular excitability, and cognition

T2 - Implications for aging

AU - Yu, Xiao Wen

AU - Oh, M Matthew

AU - Disterhoft, John F

PY - 2017/3/30

Y1 - 2017/3/30

N2 - Humans and laboratory animals display cognitive deficits as they age. However, there are currently no effective therapies available to treat these deficits, as the underlying mechanisms are poorly understood. Studies using pharmacological compounds have found a link between cognitive performance and the intrinsic cellular excitability of CA1 hippocampal neurons. Therefore, it is of great interest to identify molecular regulators that may be influencing both cognition and neuronal excitability, which could be changed with age. One possible regulator is the transcription factor cAMP response element binding-protein (CREB). In young adult animals, manipulation of CREB activity has resulted in modulation of both cognitive performance on behavioral tasks, and neuronal excitability. While evidence is sparse, studies also point to a dysfunction in CREB signaling with aging. We propose that CREB may be a viable therapeutic target for the treatment of age-related cognitive deficits, along with potential experiments to test this hypothesis.

AB - Humans and laboratory animals display cognitive deficits as they age. However, there are currently no effective therapies available to treat these deficits, as the underlying mechanisms are poorly understood. Studies using pharmacological compounds have found a link between cognitive performance and the intrinsic cellular excitability of CA1 hippocampal neurons. Therefore, it is of great interest to identify molecular regulators that may be influencing both cognition and neuronal excitability, which could be changed with age. One possible regulator is the transcription factor cAMP response element binding-protein (CREB). In young adult animals, manipulation of CREB activity has resulted in modulation of both cognitive performance on behavioral tasks, and neuronal excitability. While evidence is sparse, studies also point to a dysfunction in CREB signaling with aging. We propose that CREB may be a viable therapeutic target for the treatment of age-related cognitive deficits, along with potential experiments to test this hypothesis.

KW - Aging

KW - CA1

KW - CREB

KW - Cognition

KW - Hippocampus

UR - http://www.scopus.com/inward/record.url?scp=84994200791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994200791&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2016.07.042

DO - 10.1016/j.bbr.2016.07.042

M3 - Article

C2 - 27478142

AN - SCOPUS:84994200791

VL - 322

SP - 206

EP - 211

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -